Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock
Equities
688016
CNE100003MJ5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.42 CNY | +1.75% |
|
+8.68% | +4.16% |
| Capitalization | 14B 1.91B 1.86B 1.75B 1.57B 2.75B 166B 3.08B 21.34B 7.9B 67.97B 7.17B 7.02B 299B | P/E ratio 2024 * |
21.8x | P/E ratio 2025 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 11.49B 1.57B 1.52B 1.43B 1.29B 2.26B 136B 2.52B 17.5B 6.48B 55.75B 5.88B 5.76B 245B | EV / Sales 2024 * |
8.96x | EV / Sales 2025 * | 6.28x |
| Free-Float |
59.01% | Yield 2024 * |
1.94% | Yield 2025 * | 1.9% |
More valuation ratios
* Estimated data
More news
| 1 day | +1.75% | ||
| 1 week | +8.68% | ||
| Current month | +4.16% | ||
| 1 month | +0.37% | ||
| 3 months | +17.92% | ||
| 6 months | +20.00% | ||
| Current year | +4.16% |
1 week
103.05
115.50
1 month
103.05120.90
Current year
103.05115.50
1 year
78.62135.58
3 years
78.62173.15
5 years
78.62322.15
10 years
67.79322.15
| Director | Title | Age | Since |
|---|---|---|---|
Qing Zhu
CEO | Chief Executive Officer | 44 | 2021-07-14 |
Chun Fang Li
DFI | Director of Finance/CFO | 45 | 2021-10-27 |
Lin Lin Cai
PRN | Corporate Officer/Principal | 45 | 2018-07-30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Peng
CHM | Chairman | 57 | 2018-07-30 |
Jun Jie Zhang
BRD | Director/Board Member | 48 | 2018-07-30 |
Bao Lin Liu
BRD | Director/Board Member | 57 | 2018-07-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.20% | 0 M€ | -16.71% | - | |
| 0.00% | 127 M€ | +1.89% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.75% | +8.68% | -0.59% | -25.38% | 1.88B | ||
| +0.43% | +4.86% | +22.23% | +43.76% | 146B | ||
| +0.39% | +3.80% | -5.22% | -18.45% | 10.9B | ||
| -0.08% | -0.09% | +74.99% | +191.23% | 8.63B | ||
| +0.06% | +1.30% | -22.73% | -48.75% | 7.12B | ||
| +2.21% | -12.25% | -5.32% | -25.20% | 5.21B | ||
| +0.75% | -.--% | +3.83% | +31.79% | 3.63B | ||
| +2.55% | +4.15% | -19.02% | -65.05% | 2.54B | ||
| +0.11% | +3.17% | +2.61% | -28.78% | 2.06B | ||
| +3.56% | +20.66% | +0.23% | -32.05% | 1.9B | ||
| Average | +1.17% | +1.55% | +5.10% | +2.31% | 18.94B | |
| Weighted average by Cap. | +0.52% | +3.77% | +19.04% | +37.60% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.28B 175M 170M 160M 144M 252M 15.16B 282M 1.95B 724M 6.22B 656M 643M 27.36B | 1.72B 235M 228M 214M 192M 338M 20.31B 378M 2.62B 970M 8.34B 880M 862M 36.67B |
| Net income | 590M 80.54M 78.26M 73.62M 66.06M 116M 6.97B 130M 899M 333M 2.86B 302M 296M 12.59B | 733M 100M 97.18M 91.42M 82.03M 144M 8.66B 161M 1.12B 414M 3.56B 375M 367M 15.63B |
| Net Debt | -2.52B -343M -334M -314M -282M -495M -29.74B -553M -3.83B -1.42B -12.21B -1.29B -1.26B -53.68B | -3.21B -438M -425M -400M -359M -631M -37.91B -705M -4.89B -1.81B -15.57B -1.64B -1.61B -68.43B |
More financial data
* Estimated data
Employees
908
Calendar
2025-03-26
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-17 | 114.42 ¥ | +1.75% | 1,541,720 |
| 25-01-16 | 112.45 ¥ | +0.67% | 1,263,145 |
| 25-01-15 | 111.70 ¥ | -0.80% | 856,697 |
| 25-01-14 | 112.60 ¥ | +4.45% | 2,044,250 |
| 25-01-13 | 107.80 ¥ | +2.39% | 1,602,427 |
End-of-day quote Shanghai S.E., January 16, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
114.42CNY
Average target price
122.42CNY
Spread / Average Target
+6.99%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 688016 Stock